M3258 Is a Selective Inhibitor of the Immunoproteasome Subunit LMP7 (β5i) Delivering Efficacy in Multiple Myeloma Models

Title
M3258 Is a Selective Inhibitor of the Immunoproteasome Subunit LMP7 (β5i) Delivering Efficacy in Multiple Myeloma Models
Authors
Keywords
-
Journal
MOLECULAR CANCER THERAPEUTICS
Volume 20, Issue 8, Pages 1378-1387
Publisher
American Association for Cancer Research (AACR)
Online
2021-05-28
DOI
10.1158/1535-7163.mct-21-0005

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search